Cargando…

Lifestyle-Related Exposure to Cadmium and Lead is Associated with Diabetic Kidney Disease

Background: Environmental factors contributing to diabetic kidney disease are incompletely understood. We investigated whether blood cadmium and lead concentrations were associated with the prevalence of diabetic kidney disease, and to what extent lifestyle-related exposures (diet and smoking) contr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hagedoorn, Ilse J. M., Gant, Christina M., Huizen, Sanne v., Maatman, Ronald G. H. J., Navis, Gerjan, Bakker, Stephan J. L., Laverman, Gozewijn D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463543/ https://www.ncbi.nlm.nih.gov/pubmed/32751456 http://dx.doi.org/10.3390/jcm9082432

Ejemplares similares

Clinical and Dietary Determinants of Muscle Mass in Patients with Type 2 Diabetes: Data from the Diabetes and Lifestyle Cohort Twente
por: Jalving, Annis C., et al.
Publicado: (2021)

Glycaemic control in the diabetes and Lifestyle Cohort Twente: A cross‐sectional assessment of lifestyle and pharmacological management on Hba1c target achievement
por: Jalving, Annis C., et al.
Publicado: (2018)

Integrated Assessment of Pharmacological and Nutritional Cardiovascular Risk Management: Blood Pressure Control in the DIAbetes and LifEstyle Cohort Twente (DIALECT)
por: Gant, Christina M., et al.
Publicado: (2017)

Real-life achievement of lipid-lowering treatment targets in the DIAbetes and LifEstyle Cohort Twente: systemic assessment of pharmacological and nutritional factors
por: Gant, Christina M., et al.
Publicado: (2018)

Body weight course in the DIAbetes and LifEstyle Cohort Twente (DIALECT-1)—A 20-year observational study
por: Gant, Christina M., et al.
Publicado: (2019)

Higher Dietary Magnesium Intake and Higher Magnesium Status Are Associated with Lower Prevalence of Coronary Heart Disease in Patients with Type 2 Diabetes
por: Gant, Christina M., et al.
Publicado: (2018)

Personalized Nutrition in Patients with Type 2 Diabetes and Chronic Kidney Disease: The Two-Edged Sword of Dietary Protein Intake
por: Oosterwijk, Milou M., et al.
Publicado: (2022)

Low Physical Activity in Patients with Complicated Type 2 Diabetes Mellitus Is Associated with Low Muscle Mass and Low Protein Intake
por: Hagedoorn, Ilse J. M., et al.
Publicado: (2020)

High Dietary Intake of Vegetable Protein Is Associated With Lower Prevalence of Renal Function Impairment: Results of the Dutch DIALECT-1 Cohort
por: Oosterwijk, Milou M., et al.
Publicado: (2019)

Improvement of Sodium Status to Optimize the Efficacy of Renin-Angiotensin System Blockade
por: Laverman, Gozewijn D., et al.
Publicado: (2011)

Determinants of Increased Serum Calprotectin in Patients with Type 2 Diabetes Mellitus
por: Oosterwijk, Milou M., et al.
Publicado: (2020)

Lower Renal Function Is Associated With Derangement of 11-β Hydroxysteroid Dehydrogenase in Type 2 Diabetes
por: Gant, Christina Maria, et al.
Publicado: (2018)

Adherence to Statin Therapy and Attainment of LDL Cholesterol Targets in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)
por: Beernink, Jelle M., et al.
Publicado: (2022)

Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels
por: Gant, Christina M., et al.
Publicado: (2017)

Impact of Moderate Sodium Restriction and Hydrochlorothiazide on Iodine Excretion in Diabetic Kidney Disease: Data from a Randomized Cross-Over Trial
por: Binnenmars, S. Heleen, et al.
Publicado: (2019)

Requirements of an Application to Monitor Diet, Physical Activity and Glucose Values in Patients with Type 2 Diabetes: The Diameter
por: den Braber, Niala, et al.
Publicado: (2019)

Indomethacin Reduces Glomerular and Tubular Damage Markers but Not Renal Inflammation in Chronic Kidney Disease Patients: A Post-Hoc Analysis
por: de Borst, Martin H., et al.
Publicado: (2012)

Glucose Regulation Beyond HbA(1c) in Type 2 Diabetes Treated With Insulin: Real-World Evidence From the DIALECT-2 Cohort
por: den Braber, Niala, et al.
Publicado: (2021)

Vitamin K Intake and Plasma Desphospho-Uncarboxylated Matrix Gla-Protein Levels in Kidney Transplant Recipients
por: Boxma, Paul Y., et al.
Publicado: (2012)

Lifestyle, Inflammation, and Vascular Calcification in Kidney Transplant Recipients: Perspectives on Long-Term Outcomes
por: Sotomayor, Camilo G., et al.
Publicado: (2020)

Use of maximal dosage renin-angiotensin-aldosterone system inhibitors in a real life population of complicated type 2 diabetes – contraindications and opportunities
por: Gant, C. M., et al.
Publicado: (2023)

Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony
por: Yeung, Stanley M. H., et al.
Publicado: (2020)

Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial
por: Slagman, Maartje C J, et al.
Publicado: (2011)

Lifestyle intervention to improve quality of life and prevent weight gain after renal transplantation: Design of the Active Care after Transplantation (ACT) randomized controlled trial
por: Klaassen, Gerald, et al.
Publicado: (2017)

Cadmium and Lead Exposure, Nephrotoxicity, and Mortality
por: Satarug, Soisungwan, et al.
Publicado: (2020)

Does Exposure of Lead and Cadmium Affect the Endometriosis?
por: Kim, Min-Gi, et al.
Publicado: (2021)

Effects of Environmental Exposure to Cadmium and Lead on the Risks of Diabetes and Kidney Dysfunction
por: Yimthiang, Supabhorn, et al.
Publicado: (2022)

Pancreatic β-Cell Dysfunction and Risk of New-Onset Diabetes After Kidney Transplantation
por: Zelle, Dorien M., et al.
Publicado: (2013)

Efficacy of metformin versus sulfonylurea derivative in HNF4A-MODY
por: Oosterom, Nicole, et al.
Publicado: (2022)

Exposure–response relationships for the sodium‐glucose co‐transporter‐2 inhibitor dapagliflozin with regard to renal risk markers
por: Kroonen, Marjolein Y. A. M., et al.
Publicado: (2020)

The association of cadmium and lead exposures with red cell distribution width
por: Peters, Junenette L., et al.
Publicado: (2021)

Separate and combined effects of individual and neighbourhood socio-economic disadvantage on health-related lifestyle risk factors: a multilevel analysis
por: Zhu, Yinjie, et al.
Publicado: (2021)

Toxic Effect of Acute Cadmium and Lead Exposure in Rat Blood, Liver, and Kidney
por: Andjelkovic, Milena, et al.
Publicado: (2019)

Polyphenols and Novel Insights Into Post-kidney Transplant Complications and Cardiovascular Disease: A Narrative Review
por: Bustos, Nicolas I., et al.
Publicado: (2021)

Lead, Mercury, and Cadmium Exposure in the Korean General Population
por: Eom, Sang-Yong, et al.
Publicado: (2017)

Epigenetics, obesity and early-life cadmium or lead exposure
por: Park, Sarah S, et al.
Publicado: (2017)

Dietary Patterns Based on Estimated Glomerular Filtration Rate and Kidney Function Decline in the General Population: The Lifelines Cohort Study
por: Cai, Qingqing, et al.
Publicado: (2020)

The relationship between blood pressure and environmental exposure to lead and cadmium in Belgium.
por: Staessen, J, et al.
Publicado: (1988)

Metabolic profiling detects early effects of environmental and lifestyle exposure to cadmium in a human population
por: Ellis, James K, et al.
Publicado: (2012)

Longitudinal investigation of exposure to arsenic, cadmium, and lead in drinking water.
por: Ryan, P B, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_2kok5eh9mbp1ahkujbnev8m5g9